Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

Presentation TCT 2025

Lecture with Case Illustration: How to Respond to Hemodynamic Collapse During PCI

Presenter: Ricardo Santiago

October 28, 2025

Presentation TCT 2025

TCT 481: Strike Early, Strike Strong—But Retest Early as Well: Two-Week LDL-C Assessment Accurately Identifies Non-Responders to Triple Oral Lipid-Lowering Therapy in ACS Patients Undergoing PCI

Presenter: Kunal Mahajan

October 27, 2025

Presentation THT 2025

HFpEF in Focus: The Scientific Rationale for the Confirmatory RESPONDER HF Trial

Presenter: Sanjiv Shah

February 12, 2025

Presentation TCT 2024

TCT 1553: Novel Use of Continuous Mechanical Thrombectomy in Chronically Occluded Stents: Do All Stents Respond Equally?

Presenter: Cody Dorton

October 29, 2024

Presentation TCT 2024

IASDs: Do We Just Need to Get the PATIENT POPULATION(s) Right?

Presenter: Sheldon Litwin

October 28, 2024

Presentation TCT 2024

IASDs: Do We Just Need to Get the SIZE Right?

Presenter: Michael Pfeiffer

October 28, 2024

Presentation TCT 2024

IASDs: Is the Concept Fundamentally Flawed?

Presenter: Nir Uriel

October 28, 2024

Presentation TCT 2024

Overview of IASD Trials: Where Do We Stand?

Presenter: JoAnn Lindenfeld

October 28, 2024

Presentation TCT 2024

Interatrial Shunts (IASD): From Theory to Clinical Trials

Presenter: Javed Butler

October 28, 2024

Presentation THT 2024

AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial

Presenter: Deya Alkhatib

March 06, 2024

Presentation THT 2023

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Presenter: NULL

March 22, 2023

Presentation THT 2023

The PRELIEVE trial: Final 1-year outcomes of the prospective Atrial Flow Regulator study in HFrEF and HFpEF patients and post-hoc responder analysis

Presenter: Christina Paitazoglou

March 20, 2023

Presentation TCT 2021

Adapting Clinical Trials to a Black Swan Event, from Industry Perspective

Presenter: Sandeep Brar

November 04, 2021

Presentation TCT 2021

Adapting Clinical Trials to a Black Swan Event, from the FDA Perspective

Presenter: Andrew Farb

November 04, 2021

Presentation TCT 2020

TCT 108: The RESPOND EDGE Registry: An Interim Analysis of Early Clinical Outcomes in the First 100 Enrolled Patients

Presenter: Nicolas Dumonteil

October 14, 2020

RV Support in Cardiogenic Shock: Who, When, and How?

Presentation TCT 2020

TCT 108: The RESPOND EDGE Registry: An Interim Analysis of Early Clinical Outcomes in the First 100 Enrolled Patients

Presenter: Nicolas Dumonteil

October 14, 2020

Presentation TCT 2019

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Presenter: Naomi Fisher

September 28, 2019

Presentation TCT 2018

Predicting Responders vs Non-Responders How to Solve the Unmet Need?

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Justin E. Davies

September 24, 2018

Presentation TCT 2018

Informal Comments: Kuwait Responds to Ukraine on Management of Extensive Thrombus During STEMI PCI

Presenter: Ahmed Magdy, Mohammad Al-Mutairi

September 22, 2018

Presentation TCT 2018

Informal Comments: Egypt Responds to Columbia on Unexpected PCI Complications

Presenter: Ahmed Magdy, Adel El Etriby

September 22, 2018

Advertisement

Lecture with Case Illustration: How to Respond to Hemodynamic Collapse During PCI

TCT 481: Strike Early, Strike Strong—But Retest Early as Well: Two-Week LDL-C Assessment Accurately Identifies Non-Responders to Triple Oral Lipid-Lowering Therapy in ACS Patients Undergoing PCI

HFpEF in Focus: The Scientific Rationale for the Confirmatory RESPONDER HF Trial

TCT 1553: Novel Use of Continuous Mechanical Thrombectomy in Chronically Occluded Stents: Do All Stents Respond Equally?

IASDs: Do We Just Need to Get the PATIENT POPULATION(s) Right?

IASDs: Do We Just Need to Get the SIZE Right?

IASDs: Is the Concept Fundamentally Flawed?

Overview of IASD Trials: Where Do We Stand?

Interatrial Shunts (IASD): From Theory to Clinical Trials

AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

The PRELIEVE trial: Final 1-year outcomes of the prospective Atrial Flow Regulator study in HFrEF and HFpEF patients and post-hoc responder analysis

Adapting Clinical Trials to a Black Swan Event, from Industry Perspective

Adapting Clinical Trials to a Black Swan Event, from the FDA Perspective

TCT 108: The RESPOND EDGE Registry: An Interim Analysis of Early Clinical Outcomes in the First 100 Enrolled Patients

TCT 108: The RESPOND EDGE Registry: An Interim Analysis of Early Clinical Outcomes in the First 100 Enrolled Patients

Device-Based Hypertension Treatments: Defining Responders and Predictors of Response

Predicting Responders vs Non-Responders How to Solve the Unmet Need?

Informal Comments: Kuwait Responds to Ukraine on Management of Extensive Thrombus During STEMI PCI

Informal Comments: Egypt Responds to Columbia on Unexpected PCI Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content